United States Biotechnology & Medical Research

Kinnate Biopharma Inc (KNTE)

Track

Ticker: KNTE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kinnate Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Foresite Capital Management IV, LLC
2 purchases — total 4,984,000 USD
Buy 8 May 2023
Value US$2,730,835.43 | Price 299.87 | Shares 98,802
Buy 8 May 2023
Value US$1,185,046.66 | Price 436.51 | Shares 80,978
Buy 8 May 2023
Value US$1,712,713.55 | Price 166.59 | Shares 21,217
Buy 8 May 2023
Value US$2,156,970.21 | Price 143.94 | Shares 21,019
Buy 5 May 2023
Value US$1,383,241.02 | Price 2.82 | Shares 490,511
Buy 5 May 2023
Value US$1,383,243.84 | Price 2.82 | Shares 490,512
Buy 5 May 2023
Value US$1,383,241.02 | Price 2.82 | Shares 490,511
Buy 5 May 2023
Value US$1,383,243.84 | Price 2.82 | Shares 490,512
Buy 4 May 2023
Value US$229,512.25 | Price 2.75 | Shares 83,459
Buy 4 May 2023
Value US$860,725.25 | Price 2.75 | Shares 312,991
Buy 4 May 2023
Value US$229,512.25 | Price 2.75 | Shares 83,459
Buy 4 May 2023
Value US$229,512.25 | Price 2.75 | Shares 83,459
Buy 4 May 2023
Value US$860,725.25 | Price 2.75 | Shares 312,991
Buy 4 May 2023
Value US$229,512.25 | Price 2.75 | Shares 83,459
Buy 2 May 2023
Value US$157,065.42 | Price 2.67 | Shares 58,826
Buy 2 May 2023
Value US$589,028.70 | Price 2.67 | Shares 220,610
Buy 2 May 2023
Value US$157,065.42 | Price 2.67 | Shares 58,826
Buy 2 May 2023
Value US$157,065.42 | Price 2.67 | Shares 58,826
Buy 2 May 2023
Value US$589,028.70 | Price 2.67 | Shares 220,610
Buy 2 May 2023
Value US$157,065.42 | Price 2.67 | Shares 58,826
Buy 1 May 2023
Value US$326,307.90 | Price 2.62 | Shares 124,545
Buy 1 May 2023
Value US$1,223,718.16 | Price 2.62 | Shares 467,068
Buy 1 May 2023
Value US$326,305.28 | Price 2.62 | Shares 124,544
Buy 1 May 2023
Value US$326,307.90 | Price 2.62 | Shares 124,545
Buy 1 May 2023
Value US$1,223,718.16 | Price 2.62 | Shares 467,068
Buy 1 May 2023
Value US$326,305.28 | Price 2.62 | Shares 124,544
Buy 28 Apr 2023
Value US$155,542.35 | Price 2.55 | Shares 60,997
Buy 28 Apr 2023
Value US$583,322.70 | Price 2.55 | Shares 228,754
Buy 28 Apr 2023
Value US$155,544.90 | Price 2.55 | Shares 60,998
Buy 28 Apr 2023
Value US$155,542.35 | Price 2.55 | Shares 60,997
Buy 28 Apr 2023
Value US$583,322.70 | Price 2.55 | Shares 228,754
Buy 28 Apr 2023
Value US$155,544.90 | Price 2.55 | Shares 60,998
Buy 14 Mar 2022
Value US$209,250.00 | Price 8.37 | Shares 25,000
Planned buy 11 Mar 2022
Value US$129,600.00 | Price 8.64 | Shares 15,000
Buy 15 Feb 2022
Value US$89,640.00 | Price 9.96 | Shares 9,000
Buy 15 Feb 2022
Value US$89,640.00 | Price 9.96 | Shares 9,000
Buy 14 Feb 2022
Value US$98,900.00 | Price 9.89 | Shares 10,000
Buy 14 Feb 2022
Value US$206,586.00 | Price 9.98 | Shares 20,700
Buy 14 Feb 2022
Value US$98,900.00 | Price 9.89 | Shares 10,000
Buy 14 Feb 2022
Value US$206,586.00 | Price 9.98 | Shares 20,700
Buy 11 Feb 2022
Value US$1,594,320.00 | Price 10.22 | Shares 156,000
Buy 11 Feb 2022
Value US$1,594,320.00 | Price 10.22 | Shares 156,000
Buy 3 Dec 2020
Value US$2,500,000.00 | Price 20.00 | Shares 125,000
Buy 3 Dec 2020
Value US$7,500,000.00 | Price 20.00 | Shares 375,000
Buy 3 Dec 2020
Value US$10,000,000.00 | Price 20.00 | Shares 500,000
Buy 2 Dec 2020
Value US$9,000,000.00 | Price 20.00 | Shares 450,000
Buy 2 Dec 2020
Value US$6,000,000.00 | Price 20.00 | Shares 300,000
Buy 2 Dec 2020
Value US$9,000,000.00 | Price 20.00 | Shares 450,000
Buy 2 Dec 2020
Value US$6,000,000.00 | Price 20.00 | Shares 300,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-10 2023-05-08 B Purchase
2.1
Foresite Capital Management IV, LLC
Large shareholder
98,802 +47.6%
299.87
US$2,730,835 		98,802 +47.6% 299.87 US$2,730,835
2023-05-10 2023-05-08 B Purchase
2.1
Foresite Capital Management IV, LLC
Large shareholder
80,978 +40.7%
436.51
US$1,185,047 		80,978 +40.7% 436.51 US$1,185,047
2023-05-10 2023-05-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
21,217 -36.8%
166.59
US$1,712,714 		21,217 -36.8% 166.59 US$1,712,714
2023-05-10 2023-05-08 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
1,550,956 +78.5%
2.80
US$4,342,677 		1,550,956 +78.5% 2.80 US$4,342,677
2023-05-08 2023-05-05 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
490,511 +55.9%
2.82
US$1,383,241 		490,511 +55.9% 2.82 US$1,383,241
2023-05-08 2023-05-05 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
490,512 +55.9%
2.82
US$1,383,244 		490,512 +55.9% 2.82 US$1,383,244
2023-05-08 2023-05-05 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
490,511 +55.9%
2.82
US$1,383,241 		490,511 +55.9% 2.82 US$1,383,241
2023-05-08 2023-05-05 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
490,512 +55.9%
2.82
US$1,383,244 		490,512 +55.9% 2.82 US$1,383,244
2023-05-08 2023-05-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
83,459 +10.5%
2.75
US$229,512 		83,459 +10.5% 2.75 US$229,512
2023-05-08 2023-05-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
312,991 +7.1%
2.75
US$860,725 		312,991 +7.1% 2.75 US$860,725
2023-05-08 2023-05-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
83,459 +10.5%
2.75
US$229,512 		83,459 +10.5% 2.75 US$229,512
2023-05-08 2023-05-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
83,459 +10.5%
2.75
US$229,512 		83,459 +10.5% 2.75 US$229,512
2023-05-08 2023-05-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
312,991 +7.1%
2.75
US$860,725 		312,991 +7.1% 2.75 US$860,725
2023-05-08 2023-05-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
83,459 +10.5%
2.75
US$229,512 		83,459 +10.5% 2.75 US$229,512
2023-05-02 2023-05-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
58,826 +8.0%
2.67
US$157,065 		58,826 +8.0% 2.67 US$157,065
2023-05-02 2023-05-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
220,610 +5.2%
2.67
US$589,029 		220,610 +5.2% 2.67 US$589,029
2023-05-02 2023-05-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
58,826 +8.0%
2.67
US$157,065 		58,826 +8.0% 2.67 US$157,065
2023-05-02 2023-05-02 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
58,826 +8.0%
2.67
US$157,065 		58,826 +8.0% 2.67 US$157,065
2023-05-02 2023-05-02 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
220,610 +5.2%
2.67
US$589,029 		220,610 +5.2% 2.67 US$589,029
2023-05-02 2023-05-02 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
58,826 +8.0%
2.67
US$157,065 		58,826 +8.0% 2.67 US$157,065
2023-05-02 2023-05-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
124,545 +20.4%
2.62
US$326,308 		124,545 +20.4% 2.62 US$326,308
2023-05-02 2023-05-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
467,068 +12.5%
2.62
US$1,223,718 		467,068 +12.5% 2.62 US$1,223,718
2023-05-02 2023-05-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
124,544 +20.4%
2.62
US$326,305 		124,544 +20.4% 2.62 US$326,305
2023-05-02 2023-05-01 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
124,545 +20.4%
2.62
US$326,308 		124,545 +20.4% 2.62 US$326,308
2023-05-02 2023-05-01 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
467,068 +12.5%
2.62
US$1,223,718 		467,068 +12.5% 2.62 US$1,223,718
2023-05-02 2023-05-01 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
124,544 +20.4%
2.62
US$326,305 		124,544 +20.4% 2.62 US$326,305
2023-05-02 2023-04-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
60,997 +11.1%
2.55
US$155,542 		60,997 +11.1% 2.55 US$155,542
2023-05-02 2023-04-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
228,754 +6.5%
2.55
US$583,323 		228,754 +6.5% 2.55 US$583,323
2023-05-02 2023-04-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
60,998 +11.1%
2.55
US$155,545 		60,998 +11.1% 2.55 US$155,545
2023-05-02 2023-04-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
60,997 +11.1%
2.55
US$155,542 		60,997 +11.1% 2.55 US$155,542
2023-05-02 2023-04-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
228,754 +6.5%
2.55
US$583,323 		228,754 +6.5% 2.55 US$583,323
2023-05-02 2023-04-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
60,998 +11.1%
2.55
US$155,545 		60,998 +11.1% 2.55 US$155,545
2022-03-15 2022-03-14 B Purchase
3.0
Williams Richard Thomas

Chief Medical Officer

Officer
25,000 +144.2%
8.37
US$209,250 		25,000 +144.2% 8.37 US$209,250
2022-03-15 2022-03-11 PP Planned purchase
3.0
Williams Richard Thomas

Chief Medical Officer

Officer
15,000 +642.9%
8.64
US$129,600 		15,000 +642.9% 8.64 US$129,600
2022-02-15 2022-02-15 B Purchase
1.5
GORDON CARL L
Non-Executive Director
9,000 +0.3%
9.96
US$89,640 		9,000 +0.3% 9.96 US$89,640
2022-02-15 2022-02-15 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
9,000 +0.3%
9.96
US$89,640 		9,000 +0.3% 9.96 US$89,640
2022-02-15 2022-02-14 B Purchase
1.5
GORDON CARL L
Non-Executive Director
10,000 +0.3%
9.89
US$98,900 		10,000 +0.3% 9.89 US$98,900
2022-02-15 2022-02-14 B Purchase
1.5
GORDON CARL L
Non-Executive Director
20,700 +0.6%
9.98
US$206,586 		20,700 +0.6% 9.98 US$206,586
2022-02-15 2022-02-14 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
10,000 +0.3%
9.89
US$98,900 		10,000 +0.3% 9.89 US$98,900
2022-02-15 2022-02-14 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
20,700 +0.6%
9.98
US$206,586 		20,700 +0.6% 9.98 US$206,586
2022-02-15 2022-02-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director
156,000 +4.7%
10.22
US$1,594,320 		156,000 +4.7% 10.22 US$1,594,320
2022-02-15 2022-02-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director
156,000 +4.7%
10.22
US$1,594,320 		156,000 +4.7% 10.22 US$1,594,320
2020-12-04 2020-12-03 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
125,000 +inf%
20.00
US$2,500,000 		125,000 +inf% 20.00 US$2,500,000
2020-12-04 2020-12-03 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
375,000 +inf%
20.00
US$7,500,000 		375,000 +inf% 20.00 US$7,500,000
2020-12-04 2020-12-03 B Purchase
4.0
Tananbaum James B.
Non-Executive Director Large shareholder
500,000 +inf%
20.00
US$10,000,000 		500,000 +inf% 20.00 US$10,000,000
2020-12-04 2020-12-02 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
450,000 +inf%
20.00
US$9,000,000 		450,000 +inf% 20.00 US$9,000,000
2020-12-04 2020-12-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
450,000 +inf%
20.00
US$9,000,000 		450,000 +inf% 20.00 US$9,000,000
2020-12-04 2020-12-02 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
300,000 +inf%
20.00
US$6,000,000 		300,000 +inf% 20.00 US$6,000,000
2020-12-04 2020-12-02 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
300,000 +inf%
20.00
US$6,000,000 		300,000 +inf% 20.00 US$6,000,000
Explore more

More insider trading research around Kinnate Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America